reviewNew England Journal of MedicineMar 12, 2008Closed access

EGFR Antagonists in Cancer Treatment

University of Campania "Luigi Vanvitelli" · Institute for Experimental Endocrinology and Oncology · +1 more institution

PubMed
Indexed incrossrefpubmed

Abstract

Functional activation of growth factors and receptors of the epidermal growth factor receptor (EGFR) family occurs in most epithelial-cell cancers, rendering EGFR a target for cancer treatment. This article discusses the mechanisms of action of EGFR inhibitors, their anticancer activity, and clinical issues concerning their use in the treatment of patients with cancer.

Citation impact

2,053
total citations
FWCI
135.25
Percentile
100%
References
201
Citations per year

Authors

2

Topics & keywords

Keywords
  • Medicine
  • Epidermal growth factor receptor
  • EGFR inhibitors
  • Receptor
  • Cancer
  • Cancer research
  • Oncology
  • Bioinformatics
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.